215 related articles for article (PubMed ID: 29882160)
1. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.
Douglas AP; Thursky KA; Worth LJ; Drummond E; Hogg A; Hicks RJ; Slavin MA
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):166-173. PubMed ID: 29882160
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for invasive fungal infection in immunocompromised patients.
Leroy-Freschini B; Treglia G; Argemi X; Bund C; Kessler R; Herbrecht R; Imperiale A
QJM; 2018 Sep; 111(9):613-622. PubMed ID: 29917146
[TBL] [Abstract][Full Text] [Related]
3. Determining the usefulness of systematic
Gutiérrez A; Rodriguez B; Velasquez K; Gutiérrez I; García S; Múñez E; Calderón-Parra J; Callejas-Diaz A; Ramos-Martinez A; Fernandez-Cruz A
BMJ Open; 2023 Jun; 13(6):e074240. PubMed ID: 37355275
[TBL] [Abstract][Full Text] [Related]
4. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections.
Ankrah AO; Span LFR; Klein HC; de Jong PA; Dierckx RAJO; Kwee TC; Sathekge MM; Glaudemans AWJM
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):174-183. PubMed ID: 30343434
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant.
Longhitano A; Alipour R; Khot A; Bajel A; Antippa P; Slavin M; Thursky K
Transpl Infect Dis; 2021 Jun; 23(3):e13547. PubMed ID: 33338319
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.
Hot A; Maunoury C; Poiree S; Lanternier F; Viard JP; Loulergue P; Coignard H; Bougnoux ME; Suarez F; Rubio MT; Mahlaoui N; Dupont B; Lecuit M; Faraggi M; Lortholary O
Clin Microbiol Infect; 2011 Mar; 17(3):409-17. PubMed ID: 20636432
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Imaging of Invasive Fungal Infections- The Role of PET/CT.
Ankrah AO; Lawal IO; Dierckx RAJO; Sathekge MM; Glaudemans AWJM
Semin Nucl Med; 2023 Jan; 53(1):57-69. PubMed ID: 35933165
[TBL] [Abstract][Full Text] [Related]
9. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of fluorodeoxyglucose-positron emission tomography for investigation of fever in immunocompromised children.
Wang SS; Mechinaud F; Thursky K; Cain T; Lau E; Haeusler GM
J Paediatr Child Health; 2018 May; 54(5):487-492. PubMed ID: 29235187
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.
Brøndserud MB; Pedersen C; Rosenvinge FS; Høilund-Carlsen PF; Hess S
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1351-1358. PubMed ID: 30788532
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
Thrall MM; DeLoia JA; Gallion H; Avril N
Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
[TBL] [Abstract][Full Text] [Related]
15. Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.
Douglas AP; Thursky KA; Worth LJ; Harrison SJ; Hicks RJ; Slavin MA
Intern Med J; 2019 May; 49(5):615-621. PubMed ID: 30230669
[TBL] [Abstract][Full Text] [Related]
16. The Role of PET in Monitoring Therapy in Fungal Infections.
Ankrah AO; Klein HC; Span LFR; de Vries EFJ; Dierckx RAJO; Sathekge MM; Glaudemans AWJM
Curr Pharm Des; 2018; 24(7):795-805. PubMed ID: 29237376
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
[TBL] [Abstract][Full Text] [Related]
18.
Harlos C; Metser U; Poon R; MacCrostie P; Mason W
Curr Oncol; 2019 Aug; 26(4):e458-e465. PubMed ID: 31548813
[TBL] [Abstract][Full Text] [Related]
19.
Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
[TBL] [Abstract][Full Text] [Related]
20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
